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Tissue Engineered Bone Reconstruction:
The Era of Regenerative Medicine
In order to create tissues and organs for replacement,
understanding the processes of repair and regenera-
tion is essential. The regeneration and repair of tissues
are fundamentally different processes.1 Tissue regen-
eration, which readily occurs in embryos, is almost
absent in neonates (although some regenerative events
have been reported) and is never observed in adults.
Regeneration is a relatively slow process that seems to
recapitulate many but not all the steps that occur in
the embryo. In contrast, tissue repair is rapid and has
been revolutionarily selected to minimize the animal’s
vulnerability, that is, to get the animal away from danger
as soon as possible.2 It was not until the late 1980s
that tissue engineering was regarded as an independ-
ent branch of science. The term tissue engineering was
initially defined by the attendees of the first National
Science Foundation of the United States sponsored
meeting in 1988 as “application of the principles and
methods of engineering and life sciences toward fun-
damental understanding of structure–function relation-
ship in normal and pathologic mammalian tissues and
the development of biological substitutes for the repair
and regeneration of tissue or organ function”.3 In 1993,
Langer and Vacanti summarized the early develop-
ment in this field and defined tissue engineering as
“an interdisciplinary field that applies the principles 
of engineering and life sciences towards the develop-
ment of biological substitutes that restore, maintain,
or improve tissues or organ function”.4 The exercise
of interdigitating these different functional talents
into a coherent device has produced the working def-
inition of tissue engineering: “Tissue engineering is
an art and science by which synthetic compounds are
manipulated into anatomically and/or functionally
specific architectures and, when required, may be inte-
grated with biologically active agents and/or living
cells such that resultant properties of the whole are
precisely suited to support the specific cell life pre-
scribed for recipient tissues”.5 Since then, numerous
experiments have been performed to hammer out the
optimal tissue engineering approach to achieve bone
regeneration.
Mesenchymal Stem Cells for 
Bone Regeneration
The middle embryonic layer, the mesoderm, gives rise
to all of the body’s skeletal elements. The term mes-
enchyme is derived from the Greek meaning middle
(meso) infusion and refers to the ability of mesenchy-
matous cells to spread and migrate in early embryonic
development between the ectodermal and endodermal
layers. This characteristic migratory space-filling ability
is the key element of all wound repair in adult organ-
isms involving mesenchymal cells in the skin (dermis),
bone (periosteum) or muscle (perimysium). It is gen-
erally agreed that in the mesoderm of an embryo, a
mesenchymal stem cell is a pleuripotent progenitor cell
that divides many times and whose progeny eventu-
ally give rise to skeletal tissues such as bone, cartilage,
tendon and ligament. By definition, these cells are not
governed by or limited to a fixed number of mitotic
divisions.6 These cells have the capacity for extensive
replication without differentiation, and they possess 
a multilineage development potential. In fact, many
adult tissues contain populations of stem cells that
have the capacity for renewal after trauma, disease or
aging. It has been widely accepted that human bone
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marrow, apart from containing hematopoietic stem
cells, also contains mesenchymal stem cells which con-
tribute to the regeneration of different mesenchymal
tissues such as bone, cartilage, muscle, ligament, tendon
and adipose tissues.7 Subsequently, a body of evidence
has indicated that mesenchymal stem cells possess
excellent potential for bone regeneration.
Fibrin Glue as a Scaffold for 
Bone Regeneration
Scaffolds can provide necessary support for cells to main-
tain their differentiated functions and define the ulti-
mate shapes of the new bones. Before considering the
desired features of potential tissue engineering materials,
it is useful to understand two concepts of bone regen-
eration for tissue engineering constructs, specifically
osteoinduction and osteoconduction. Osteoinduction
is defined as the ability to cause pleuripotent cells, from
a nonosseous environment, to differentiate into chon-
drocytes and osteoblasts, culminating in bone for-
mation. An osteoinductive material guides repair in 
a location that would normally not heal if left untreated.
Osteoconduction supports ingrowth of capillaries and
cells from the host into a 3-dimensional structure to
form bone. An osteoconductive material guides repair
in a location where normal healing would normally
occur even if untreated.
Taking the concepts of osteoconduction and osteo-
induction into consideration, the desirable qualities
of a bone tissue-engineering scaffold design have
been postulated.5 First of all, the scaffold must be able
to promote maximal bone ingrowth through osteo-
induction and/or osteoconduction, and it does not
induce soft tissue growth at the bone/scaffold interface.
Additionally, it should: (1) not exert any detrimental
effects on surrounding tissues due to processing; (2)
be sterilizable without loss of properties; (3) be abso-
rbable with biocompatible components—preferably,
it is absorbed in a predictable manner in concert with
bone growth; (4) be malleable and adaptable to irreg-
ular bone defect sites; and (5) possess proper mechan-
ical and physical properties, in particular, in the early
stages after implantation. Most importantly, it should
be user friendly; that is, easy to apply and available to
surgeons at short notice.
One potential candidate material that may be used
as scaffolding for tissue-engineered bone tissues is 
fibrin glue. Fibrin glue is a physiologically relevant
matrix whose principal component, fibrin, has funda-
mental roles in the process of blood clotting and wound
healing. Fibrin glue, a composite of fibrinogen and
thrombin, is a potentially suitable biological vehicle for
cell transplantation because it has proven biocompati-
bility, biodegradability and binding capacity to cells.
Fibrin-stabilizing factor XIII contained in fibrin glue
favors migration of undifferentiated mesenchymal cells
on the highly cross-linked structure of the glue, and 
it enhances the proliferation of these cells. The rate of
resorption of fibrin glue can be controlled by varying
the concentration of the fibrinolytic inhibitor apoptin.8
This keeps the cells in place, increases cell survival, and
improves the immediate mechanical properties of the
implant. The fibrin extracellular matrix remains in situ
while the cells proliferate and differentiate into new
tissue, before the scaffold is completely resorbed. Most
important of all, the fibrin glue promotes angiogenesis
via chemotactic and mitogenic stimuli that promote
cell migration, proliferation and matrix synthesis.9
Our previous work has shown that fibrin glue can be
used to deliver mesenchymal stem cells to facilitate
bone regeneration in normal and chemotherapy-treated
rats.10 In this issue of the Journal of the Chinese Medical
Association, Lee et al further demonstrated the useful-
ness of autologous fibrin glue to deliver mesenchymal
stem cells for calvarial defect regeneration in rabbits.11
Their study elegantly demonstrated that autologous
fibrin glue better facilitated bone regeneration than
macroporous biphasic calcium phosphate in the pres-
ence of mesenchymal stem cells. Their results justify
further translational research to investigate the use of
autologous fibrin glue as a scaffold to facilitate bone
regeneration in non weight-bearing areas such as
craniofacial bones.
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